⌘K

Home/Filings/4/0001214659-20-002731

4//SEC Filing

Breton Jose 4

Accession 0001214659-20-002731

CIK 0000819050other

View on SEC.gov Company Profile

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:30 PM ET

Size

16.7 KB

Accession

0001214659-20-002731

Insider Transaction Report

Form 4

Period: 2020-03-16

Brickell Biotech, Inc.BBI

Chief Accounting Officer

Transactions

Award
Restricted Stock Units
2020-03-16$1.54/sh+15,000$23,100→ 15,000 total
Exercise: $1.54From: 2021-03-16Exp: 2030-03-15→ Common Stock (15,000 underlying)

Holdings

Stock Options
Exercise: $12.17From: 2015-04-22Exp: 2025-04-22→ Common Stock (345 underlying)
345
Stock Options
Exercise: $12.17From: 2016-12-15Exp: 2026-12-15→ Common Stock (2,589 underlying)
2,589
Stock Options
Exercise: $16.45From: 2019-12-15Exp: 2028-12-15→ Common Stock (5,178 underlying)
5,178
Stock Options
Exercise: $4.76From: 2020-08-30Exp: 2029-08-30→ Common Stock (26,721 underlying)
26,721
Stock Options
Exercise: $12.17From: 2015-12-23Exp: 2025-12-23→ Common Stock (1,380 underlying)
1,380
Common Stock
2,169
Stock Options
Exercise: $12.17From: 2015-09-22Exp: 2025-09-22→ Common Stock (1,726 underlying)
1,726
Stock Options
Exercise: $12.17From: 2016-08-31Exp: 2026-08-31→ Common Stock (863 underlying)
863
Stock Options
Exercise: $16.69From: 2018-12-15Exp: 2027-12-15→ Common Stock (2,589 underlying)
2,589
Warrants
Exercise: $10.36From: 2019-08-30Exp: 2029-08-30→ Common Stock (995 underlying)
995

Documents

1 file

4
marketforms-48372.xmlPrimary
PRIMARY DOCUMENT

Issuer

Brickell Biotech, Inc.

CIK 0000819050

Entity typeother

Related Parties

1

filerCIK 0001784373

Filing Metadata

Form type: 4
Filed: Mar 17, 8:00 PM ET
Accepted: Mar 18, 4:30 PM ET
Size: 16.7 KB

View on SEC.gov